Arbutus Biopharma repurchases 46,000,000 shares for USD 230 million in modified Dutch auction tender offer
Bitget2026/09/30 11:30- Arbutus Biopharma expects to repurchase 46,000,000 common shares for cancellation in a modified Dutch auction tender offer.
- Preliminary purchase price set at US$ 5.00 per share, implying US$ 230 million in total consideration.
- Offer was oversubscribed, with 65,907,215 shares tendered at or below US$ 5.00; estimated proration about 55%.
- Roivant Sciences tendered proportionately, keeping its stake near 19.5% following completion of the repurchase.
- Shares outstanding expected to fall to about 153,275,907 once the repurchase is completed.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Citi Turns More Bullish on Bitcoin and Strategy: Here Are the New Targets
South Korea's DRAM exports hit a record high of $33 billion in September.
QNT and NIGHT Continue to Defy Market Correction, BTC Settles After Wild Ride: Weekend Watch
Within just 40 days of its release, the split box office of iQIYI (IQ.US) "Soul Ferry" series of AI feature films exceeded 10 millions and continues to be popular.
From recouping initial investment in the first week to revenue sharing surpassing 10 million, AI unlocks the commercial value of classic IPs.
Crypto prices
More
